Ближайший уровень поддержки по SPY – 199.50 уровень сопротивления – 200.30
COST покупка при ужержании 125
EMES покупка выше 125
EGN смотрим на разворот
Gapping up/down: BLOX +13% and AMBA +9% after earnings, PRAN +28% after orphan designation status, CIEN +2% after upgrade; GPX -6% and FNSR -5% after earnings/SSS, KORS -5% after offering
In reaction to strong earnings/guidance: BLOX +13.4%, AMBA +9.3%, LOCO +2.9%, VRNT +2.6%.
Other news: PRAN +27.6% (received orphan designation status for its product for the treatment of Huntington’s disease), HART +13.7% (received orphan designation status for its inBreath airway transplant system to restore the structure and/or function of the trachea subsequent to tracheal damage due to cancer, injury or infection), NSPH +10.8% (has engaged Jefferies LLC as its financial advisor to assist it in the development and evaluation of a full range of potential strategic alternatives for the Company), TASR +6% (higher following announcement that the NYPD will begin a pilot program of equipping officers with body cameras), OMED +4.1% (FDA removes partial clinical hold on OncoMed’s ipafricept), ICLD +2.8% (announces multi-site deployment of security and threat prevention solutions and services for a large global consulting firm), MOBI +2.6% (announces repurchase of 16 mln shares from Sequoia Capital ), GPRO +1.7% (up in sympathy following supplier AMBA earnings), DGLY +1.5% (cont usual volatility pre-mkt), JOY +1% (positive Barron’s mention), SD +0.8% ( announces $200 mln share repurchase program)
Analyst comments: IPCI +3.7% (upgraded to Buy at Maxim Group), VRTX +2.3% (upgraded to Buy from Neutral at Goldman), CIEN +1.8% (upgraded to Buy from Neutral at Goldman), ICPT +1.8% (initiated with an Outperform at Cowen), MTRX +1.7% (upgraded to Overweight from Equal Weight at First Analysis Sec), SNDK +1.5% (upgraded to Overweight from Equal-Weight at Morgan Stanley), BLUE +1.4% (initiated with a Buy at Sun Trust Rbsn Humphrey), INSM +1.4% (initiated with an Outperform at Cowen), MBLY +1.4% (target raised to $52 at RBC Capital Mkts), IL +1.1% (upgraded to Buy at Stifel ), ING +1% (upgraded to Overweight from Equal Weight at Barclays), BEAV +1% (upgraded to Buy from Hold at Deutsche Bank), BP +0.9% (upgraded to Buy from Neutral at Citigroup), QGEN +0.6% (upgraded to Buy from Sell at DZ Bank)
In reaction to disappointing earnings/guidance: ZQK -12.4%, GPS -5.8%, ZUMZ -5.1%, FNSR -5%, SEAC -4.3%, BEBE -2.8%, BEBE -2.8%, COO -2.1%.
Other news: REPH -40.5% (announced that the Phase 2b clinical trial of Dex-IN for the treatmnet of acute post-operative pain is not expected to reach statistical significance at its current design), KORS -5.1% (Michael Kors files for ordinary share shelf offering by selling shareholders; launches secondary public offering of ordinary shares on behalf of Sportswear, one of its principal founding shareholders, for the offering of 11,629,627 ordinary shares), TUMI -4.4% (announced secondary offering of 8 mln shares of common stock by Doughty Hanson & Co. Managers Limited), PNNT -4% ( announces public offering of 11 mln shares of common stock), GLNG -3.5% (announces secondary offering of ~27.83 mln shares of its common stock by World Shipholding Ltd.), HMY -2.5% (still checking), ST -2.2% (announced offering of ~15.05 mln ordinary shares by selling shareholders), CX -2% (prices of €400 mln and $1.1 bln in Senior Secured Notes), SDRL -1.7% (still checking), AU -1.6% (still checking), GSK -1.5% (will not be able to fill all demand for flu vaccines, according to reports), GTAT -1.3% (cont vol due to speculation surrounding iPhone component), SHPG -1% (still checking).
Analyst comments: TTWO -1.3% (downgraded to Neutral from Buy at Sterne Agee), CS -1.1% (downgraded to Neutral from Buy at UBS), PCLN -0.7% (downgraded to Equal Weight from Overweight at Evercore ), MS -0.7% (downgraded to Neutral from Outperform at Macquarie).GT_support Новости фондового рынка и Торговые идеи
Ближайший уровень поддержки по SPY – 200.60 уровень сопротивления – 201.20
MNK продолжает расти выше на премаркете
GD покупка выше 125
RPRX покупка от 18
Gapping up/down: ITI +11% and PVH +8% after earnings, BOLT +36% on merger with TDY, MITK +69% on litigation settlement; CIEN -10%, SCVL -9% and JOY -2% after earnings, GPRO -3.7% after dg
In reaction to strong earnings/guidance/SSS: ITI +11.2%, MEI +10.9%, MAGS +9.9%, PVH +8.4%, BV +5.6%, DDC +4.9%, ABM +3.3%, PAY +2.5%, HRB +2%, COST +1.4%, MBLY +1%
M&A news: BOLT +36.6% (to be acquired by Teledyne (TDY) for $22 per share in cash), BWP +2.7% (to acquire Evangeline ethylene pipeline system for $295 mln in cash), SYNL +1.1% (announces sale of Ram-Fab in Crossett, Arkansas to a subsidiary of Primoris Services (PRIM)).
Other news: MITK +68.8% (announced settlement of pending litigation with USAA), SGOC +16.2% (seeing continued strength following yesterday’s 50% move higher), TIBX +7.6% (announced a review of strategic alternatives), HMSY +5.3% (modestly rebounding in premkt trade), MHGC +5.1% (announced its special transaction committee has directed Morgan Stanley to reach out to possible counterparties regarding their interest in potential transactions), TASR +3.8% (announces multiple orders of its TASER brand next generation Smart Weapons, aslo positive Mad Money mention), ISNS +3.7% (pulling back following recent gains), NLNK +2.7% (FDA gives NewLink Genetics approval to proceed to phase 1 clinical studies of their ebola vaccine), MPET +2.5% (announces drilling operations on the Horse Hill-1 well commenced on Sep 3, 2014), ALLT +2.2% (announces follow-on order with a Tier-1 global telecommunications group), ECR +2.1% (announced the commencement of production at two of the Co’s pad locations consisting of a total of 7 Utica Shale wells; co also reaffirmed its production guidance for Q3), PLUG +1.3% (announces Chris Hutter has been appointed CFO), CELG +0.9% (reported Phase III FIRST trial of REVLIMID Plus Dexamethasone)
Analyst comments: OI +2.2% (initiated with an Outperform at BMO Capital Mkts), DHI +2% (upgraded to Buy from Neutral at UBS), CERN +1.4% (resumed with a Overweight at JP Morgan), HIMX +1.3% (tgt raise at Brean Cap’l), IACI +1.2% (upgraded to Overweight from Equal Weight at Barclays), LPX +1.1% (initiated with an Outperform at BMO Capital Mkts), INFI +1.1% (upgraded to Mkt Outperform from Mkt Perform at JMP Securities), FL +0.6% (initiated with a Buy at Jefferies), COP +0.6% (target raised to $95), PKG +0.5% (initiated with an Outperform at BMO Capital Mkts)
In reaction to disappointing earnings/guidance: MTRX -15.9%, CIEN -10%, SCVL -8.7%, AVAV -6.4%, JOY -2.3%, UTIW -1%
Other news: KMDA -19.3% (eports final results from Phase 2/3 clinical trial of inhaled Alpha-1 Antitrypsin to treat Alpha-1 Antitrypsin deficiency), GNE -8.8% (stated it is considering alternative ways forward for oil shale pilot project in Israel following the Jerusalem District Committee for Planning and Building vote to decline to issue a permit to build and operate an oil shale pilot drilling project), SMLP -4.9% (announced public offering of 4 mln common units by selling unitholders), MEMP -4.8% (announced public offering of 13 mln common units), AI -3.5% (announced offering of 2.75 mln shares of common stock), YUM -3.2% (disclosed significant, negative impact to sales at both KFC and Pizza Hut in China; sees Q3 same store sales -13%), NRF -2.6% (announced public offering of 45 mln shares with a forward component), GRUB -1.4% (prices follow-on public offering of 10,468,198 shares of common stock offered by the co and certain stockholders at $40.25 per share), DEPO -0.6% (announces pricing of upsized $300 mln convertible Senior Notes due 2021)
Analyst comments: TNGO -4.1% (downgraded to Equal Weight from Overweight at Barclays), GPRO -3.7% (downgraded to Neutral from Overweight at JP Morgan), DDD -2.5% (downgraded to Sector Perform from Outperform at Pacific Crest), INFA -1% (downgraded to Equal Weight from Overweight at Barclays), LVS -0.5% (downgraded to Hold from Buy at Argus)GT_support Новости фондового рынка и Торговые идеи
Ближайший уровень поддержки по SPY – 200.80 уровень сопротивления – 201.20
Gapping up/down: DGLY +15% after guidance, CPWR +15%, FLWS 13%, and TMUS+3% on M&A news, TSLA +3% on upgrade; CONN -25% after earnings, metals and miners trading lower, OSIS -3% after dg
In reaction to strong earnings/guidance: DGLY +15.5%, FORM +2.4%, KFX +1.1%, (also announces acquisition of Softpro GmbH) ZNH +1%, GZT +0.7%.
M&A news: CPWR +15% (WSJ reporting that company is in sale discussions), FLWS +12.6% (signs definitive agreement to acquire Harry & David Holdings for $142.5 mln in cash), TMUS +2.8% (Illiad (ILIAY) in discussions with buyout firms regarding TMUS bid, according to reports), DG +1.7% (to raise bid for FDO for $80/share), TSL +1.4% (acquires Majority Stake in Yunnan Metallurgical New Energy), ARCP +0.8% (confirms Cole Corporate Income Trust entered into merger agreement relating to the sale of CCIT to Select Income REIT (SIR)), FDO +0.6% (Dollar General (DG) confirms enhanced proposal to acquire Family Dollar).
Select pharma/biotech related names showing strength: ELOS +10.5%, ZGNX +5.9% (reports that Zohydro ER demonstrates sustained 12-hour pain relief), ARNA +3.9%, NVS +3.5% (new heart failure medicine LCZ696 cut cardiovascular deaths by 20% vs. ACE-inhibitor in landmark PARADIGM-HF trial, early results of upcoming presentations).
Other news: HGSH +43.2% (signed its second shanty area rebuilding project agreement with a budgeted investment over $750 mln), ASTI +21.2% (announces new common stock investment of $8.0 mln led by largest shareholder), SYNA +4.7% (positive Barron’s mention), USG +3.5% (positive Barron’s mention), ISNS +2.4% (in sympathy with DGLY), NXPI +2.2% (reports that Apple (AAPL) may partner with Visa (envy) and Mastercard (MA) for payment applications), DTV +1.9% (still checking), OWW +1.8% (reaches an agreement with American Airlines (AAL) to continue to offer American Airlines and US Airways (LCC) flights on all of its sites), BLDP +1.8% (appoints Randy MacEwen as President and Chief Executive Officer, effective October 6, 2014), PBA +1.2% (to acquire the Vantage pipeline system and Mistral Midstream’s interest in the Saskatchewan Ethane Extraction Plant), NBG +0.9% (still checking), YHOO +0.8% (Alibaba.com to begin roadshow next week, according to reports).
Analyst comments: SPLS +4.9% (upgraded to Outperform from Neutral at Credit Suisse), SD +3.4% (upgraded to Buy at Stifel), CENX +3% (upgraded to Overweight from Equal-Weight at Morgan Stanley), GRPN +2.9% (upgraded to Sector Perform at RBC Capital Mkts), STO +2.9% (upgraded to Buy from Hold at Deutsche Bank), TSLA +2.9% (upgraded to Buy from Hold at Stifel), DSKY +2.6% (initiated with a Overweight at Piper Jaffray), ACHN +2.6% (tgt raised to $15 from $11 at UBS), TS +2.4% (upgraded to Neutral from Sell), RCAP +1.9% (upgraded to Buy from Neutral at Citigroup), ZU +1.5% (upgraded to Buy from Fair Value at CRT Capital), ANET +1.3% (initiated with a Buy at Sun Trust Rbsn Humphrey), COG +1% (upgraded to Buy at Stifel), AAPL +0.8% (target raised to $120 from $105 at Piper Jaffray)
In reaction to disappointing earnings/guidance: CONN -25.5%, VIVO -0.6%.
Select pharma/biotechl related names showing weakness: AMPE -5.1% (announces update on the phase III, multicenter, double-blind STEP study of Ampion for osteoarthritis of the knee), GSK -1.6%, AZN -1.1%.
Select metals/mining stocks trading lower: GFI -2.5%, PAAS -2.4%, NEM -2.1%, GG -2%, GDX -1.8%, SLV -1.7%, GOLD -1.7%, GLD -1.6%, SLW -1.4%, .
Other news: EXEL -52.4% (announces results from the COMET-1 Phase 3 pivotal trial of Cabozantinib in men with metastatic castration-resistant prostate cancer), RIBT -17.4% (disclosed its Irgovel plant experienced a structural breakdown; co withdraws prior guidance), TWGP -11.9% (received a letter from the SEC stating that the SEC is conducting an investigation and attaching a subpoena for various documents), PT -2.7% (still checking), LXRX -1.3% (files for $150 mln mixed securities shelf offering), PXLW -1.2% (files $50 mln common stock shelf offering), HSBC -0.9% (stake sold by Fund Manager Neil Woodford, according to reports), CREE -0.7% (LED demand fell in Q3 QoQ, according to reports (not stock specific)).
Analyst comments: OSIS -3.1% (downgraded to Perform from Outperform at Oppenheimer), FNSR -2.5% (downgraded to Hold from Buy at Jefferies), EMES -1.7% (downgraded to Neutral at Robert W. Baird on valuation), FCX -0.5% (downgraded to Equal-Weight from Overweight).GT_support Новости фондового рынка и Торговые идеи
Ближайший уровень поддержки по SPY – 200.50 уровень сопротивления – 200.85
EMES покупка выше 141
SLCA покупка выше 71.50
MNK покупка выше 80.50
BOBE смотрим на откат вверх
Gapping up/down: SPLK +7% and RALY +6% after eranings, CRTO +21% on M&A spec, TSLA +2% on deal with CHU, SSYS +1.5% after Buy initiation; ZOES -1% on earnings, GOMO -1% after dg at CS
In reaction to strong earnings/guidance: UEPS +17.9%, VEEV +12.2%, SPLK +6.7%, RALY +6.4%, ANFI +5.4%, AVGO +5.3%, PSUN +4.3%, BONA +3.9%, FRED +2.9%, CO +2.3%, OVTI +2.3%.
M&A news: CRTO +20.7% (may be attributed to Publicis (PUBGY) speculation), AZN +2.2% (reports that Pfizer (PFE) and AZN may have resumed merger talks), .
Select Biotech related names showing strength: FOLD +5.2%, AEZS +3.6%, KERX +0.7%, ACHN +0.5%.
Other news: DGLY +7.1% (continue momentum higher), BCRX +4.1% (receives additional NIAID funding to conduct a non-human primate study of BCX4430 in Ebola virus disease), RSH +3.5% (cont strength), CHU +3.4% (agreement with Tesla for charging stations), NXPI +3% (Apple and NXP Semi (NXPI) working on payment system technology for iPhone, according to reports), KNDI +2.1% (China considering new tax on gasoline to help electric car market, according to reports), TSLA +1.7% (has agreed to deal with China Unicom (CHU) for charging stations, according to reports)
Analyst comments: SSYS +1.5% (initiated with a Buy at Stifel), CRH +1.1% (upgraded to Buy from Neutral at Goldman)
In reaction to disappointing earnings/guidance: ZOES -1.3%, BIG -0.5%
Select Russia related names showing weakness (Russian stocks downgraded at Morgan Stanley): MBT -3.8% (also dg’d at DB, see below), RSX -1.3%, VIP -1%, YNDX -0.9%.
Other news: ISNS -6.6% (may be related to large shareholder selling shares), FRO -2.2% (cont weakness), NOAH -1.2% (still checking), MCHP -0.6% (co confirmed it is in preliminary discussions with CSR plc).
Analyst comments: MBT -3.8% (downgraded to Hold from Buy at Deutsche Bank), GOMO -1.2% (downgraded to Neutral from Outperform at Credit Suisse).GT_support Новости фондового рынка и Торговые идеи
Ближайший уровень поддержки по SPY – 199.45 уровень сопротивления – 200.00
HUM продажа ниже 127
BITA продажа ниже 88
ATHM продажа ниже 50
QIHU продажа ниже 88
GMCR продажа ниже 134
Gapping up/down: SIG +3% after earnings, DGLY +14% after new order announcement, RPRX +12% after study results, FEYE +2% after initiation w/Buy; GOMO-22%, GES -8.3% and ANF -6% after earnings, GTAT -2% after dg
In reaction to strong earnings/guidance: EDAP +4.2%, SIG +2.7%, VNET +2%, DATE +1.8%, LCI +1.7%, WDAY +1.3%.
Select metals/mining stocks trading higher: GFI +2.2%, SLV +1.7%, HL +1.6%, GG +1.4%, IAG +1.3%, AEM +1.3%, SLW +1.3%, ABX +1.3%, AUY +1.3%, GOLD +0.8%.
Other news: CREG +24.5% (Chairman Guohua Ku has entered into a share purchase agreement to purchase ~13.83 mln shares at $1.37/share), DGLY +13.8% (receives order from State Police Of Michigan valued at more than $1.1 mln), ETRM +13.1% (announces three year diabetes, hypertension and weight loss data from the Maestro RC system DM2 ENABLE study), RPRX +12.6% (achieves superiority in top line analysis for both co-primary endpoints and various secondary endpoints versus marketed topical gel in first of two identical studies in the treatment of secondary hypogonadism), TKMR +9.4% (story suggesting it is a takeover candidate; lists GlaxoSmithKline (GSK) and Shire (SHPG) as interested parties), SYN +8.1% (Co and FUJIFILM Diosynth Biotechnologies UK announce significant improvement in API manufacturing of SYN-004 for the prevention of C. difficile), SCLN +7.5% (and BTG announce that DC Bead has been approved by China FDA ), MRCY +2% (receives $27 mln order for airborne sensor processing application; follows $39 mln missile defense radar subsystems order received last quarter ), WOOF +1.7% (announces new $1.4 billion credit facility and share repurchase authorization of up to $400 million), AVIV +1.7% (to join the S&P SmallCap 600), CNC +1.5% (to join the S&P MidCap 400)
Analyst comments: FEYE +1.7% (initiated with a Buy at Stifel), CRH +1.5% (upgraded to Outperform from Underperform at Credit Suisse), PANW +0.9% (resumed with a Buy at Stifel), FHN +0.8% (upgraded to Outperform from Mkt Perform at Keefe Bruyette), GOLD +0.8% (upgraded to Neutral from Underweight at HSBC Securities), SMTC +0.8% (resumed with a Buy at Goldman)
In reaction to disappointing earnings/guidance: GOMO -21.8%, WSM -10.5%, TLYS -9.6%, FRO -8.9%, GES -8.3%, GCO -6.5%, ANF -6.1%, GMAN -5.8%, HSOL -5.5%, VE -1.7%, VMEM -1.2%, .
M&A news: TEF -0.8% (raises bid offer for Vivendi’s (VIVHY) GVT unit).
Select EU financial related names showing weakness: DB -2.1%, SAN -1.7%, UBS -0.8%
Select metals/mining stocks trading lower after Austrian steelmaker Voestalpine AG sees drop in iron ore prices due to over supply: RIO -3.6%, MT -2.1%, BHP -1.9%, CLF -1.9%.
Select Biotech related names showing early weakness: ISNS -4.2%, FOLD -3.1%, MACK -1.8%, ARWR -1.8%, ACHN -1.5%, ARIA -1.1%
Other news: ROX -7.3% ((filed for $30 mln mixed securities shelf offering), TIF -0.5% (filed mixed securities shelf offering),), RSH -3.7% (pulling back from yesterday’s 20% gain), FOLD -3.1% (still checking), RSX -3.1% (new reports of Russian invasion into Ukraine), AEO -2.3% (in sympathy with ANF), RH -2% (following WSM results), YNDX -1.8% (Russian exposure).
Analyst comments: GTAT -2.2% (downgraded to Underperform from Mkt Perform at Raymond James), NOK -2% (removed from Europe 1 List at BofA/Merrill ), HTZ(e) -1.2% (heaing estimates cut at MS), V -0.8% (downgraded to Mkt Perform from Outperform at Raymond James)GT_support Новости фондового рынка и Торговые идеи
Чтобы первыми узнавать последние новости советуем вам подписаться на RSS
Лучшие посты месяца
- Кубок Роббинса (The World Cup Trading Championships)
- Марк Дуглас — Разум над рынком (интервью)
- Трансляция сделок Day Trading на NYSE, NASDAQ — live show
- Рабочий стол трейдера, своими руками(10 мониторов)
- Обучение интернет трейдингу на бирже. Обучение торговле акциями на фондовом рынке
- Лучшие Фильмы про фондовую биржу и трейдеров — скачать бесплатно
- NYSE -New York Stock Exchange
- Multicharts торговая платформа — описание (скачать)
- Книга Фондовый рынок США для начинающих инвесторов скачать pdf epub (Фридом Финанс) скачать
- William Delbert Gann
- AlexSiler on Книга Фондовый рынок США для начинающих инвесторов скачать pdf epub (Фридом Финанс) скачать
- Dmitrii Kazantsev on Книга Фондовый рынок США для начинающих инвесторов скачать pdf epub (Фридом Финанс) скачать
- Vladimir Eremeev on Книга Фондовый рынок США для начинающих инвесторов скачать pdf epub (Фридом Финанс) скачать
- Леонид Сухарев on Книга Фондовый рынок США для начинающих инвесторов скачать pdf epub (Фридом Финанс) скачать
- Статистика по счету для live show | Dаy trading на фондовой бирже США (NYSE, NASDAQ, AMEX - акции) Блог трейдера. Обучение. Инвестиции on Брокеры
- Видео о Time & Sales (Чтение ленты)
- Постулаты Ланса Бегса
- Лучшие Фильмы про фондовую биржу и трейдеров — скачать бесплатно
- Обучение интернет трейдингу на бирже. Обучение торговле акциями на фондовом рынке
- Управление рисками при инвестировании в биотехнологии
- Макс Гюнтер — Аксиомы биржевого спекулянта(аудиокнига)
- Использование и настройка Takion для дэй трейдера
- NYSE -New York Stock Exchange
- ECN — Electronic Communication Network (ARCA,BATS,NSDQ,EDGA,ISLD,SDOT)